A study in the journal "Circulation" finds that the level of the bone density regulator, osteoprotegerin, is strongly predictive of cardiovascular disease and stroke. See:
"Lou Pagnucco" <[email hidden]> wrote in message "]news:[email hidden]...
Quoted message said:
A study in the journal "Circulation" finds that the level of the bone density regulator, osteoprotegerin, is strongly predictive of cardiovascular disease and stroke. See:
Osteoprotegerin levels may be increased by bisphosphonates typically prescribed for osteoporosis. See:
"Bisphosphonates Pamidronate and Zoledronate stimulate Osteoprotegerin Production by Primary Human Osteoblasts" thieme.devOpen ↗ 048.html
This raises the question whether bisphosphonates may increase the risk of vascular disease.
Any comments?
That's possible. Though I was thinking it could also be the other way around. Could statins lower bone mass density as an offshoot of their cardio-protective effect? I've been taking statins for several years and, despite taking Fosomax, have been seeing a decrease in BMD. (I realize this is just one case, so it is just a question.)
